pre-IPO PHARMA

COMPANY OVERVIEW

Vedantra Pharmaceuticals, Inc. is an immunotherapy company focused on developing products for cancer and infectious diseases. Vedantra’s technologies enlist both antibody and T-cell responses that impair and destroy pathogens before they can replicate and cause serious damage in the body.


LOCATION

  • Cambridge, MA, USA

  • THERAPEUTIC AREAS

  • Immunology
  • Infectious Disease
  • Oncology

  • WEBSITE

    https://vedantra.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS

    access-bridgegap-ventures thynk-capital


    PRESS RELEASES


    Oct 31, 2017

    Vedantra Pharmaceuticals Extends Research Collaboration with Neon Therapeutics to Develop Novel Cancer Immunotherapies


    Mar 14, 2017

    Vedantra Pharmaceuticals Announces a Joint Research Collaboration with Neon Therapeutics to Develop Cancer Vaccines


    Jan 9, 2017

    Julian Adams, Ph.D. Joins Vedantra Pharmaceuticals as Executive Chairman


    For More Press Releases


    Google Analytics Alternative